Cargando…
Changes in Thyroid Metabolites after Liothyronine Administration: A Secondary Analysis of Two Clinical Trials That Incorporated Pharmacokinetic Data
We examined relationships between thyroid hormone (TH) metabolites in humans by measuring 3,5-diiodothyronine (3,5-T2) and 3-iodothyronamine (3-T1AM) levels after liothyronine administration. In secondary analyses, we measured 3,5-T2 and 3-T1AM concentrations in stored samples from two clinical tria...
Autores principales: | Diab, Nour, Desale, Sameer, Danielsen, Mark, Köhrle, Josef, Shara, Nawar, Jonklaas, Jacqueline |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227779/ https://www.ncbi.nlm.nih.gov/pubmed/35736409 http://dx.doi.org/10.3390/metabo12060476 |
Ejemplares similares
-
Short-Term Time Trends in Prescribing Therapy for Hypothyroidism: Results of a Survey of American Thyroid Association Members
por: Jonklaas, Jacqueline, et al.
Publicado: (2019) -
3,5-T2—A Janus-Faced Thyroid Hormone Metabolite Exerts Both Canonical T3-Mimetic Endocrine and Intracrine Hepatic Action
por: Köhrle, Josef, et al.
Publicado: (2020) -
MON-LB101 Pharmacokinetics of Liothyronine during Thyroid Hormone Therapy Withdrawal
por: Celi, Francesco, et al.
Publicado: (2019) -
The ages and TSH values of patients being prescribed levothyroxine
por: Jonklaas, Jacqueline, et al.
Publicado: (2020) -
Levothyroxine prescriptions trends may indicate a downtrend in
prescribing
por: Jonklaas, Jacqueline, et al.
Publicado: (2020)